Daily non-political popular news in brief.
Mayo Clinic study unveils unprecedented method to predict ALS, Parkinson's disease
01-15-2008 · EurekAlert!A new Mayo Clinic study details an unprecedented method to predict brain aging disorders such as amyotrophic lateral sclerosis and Parkinson's disease. Investigators studied common variations within axon guidance pathway genes and identified several gene variations (DNA fingerprints) that collectively predicted people who are at a high risk for ALS (2,000 times greater than the average risk).
Read more »
Keywords: mayo, clinic, study, unveils, unprecedented, method, predict, als, parkinson, disease, unveil
« Previous | Next »
Similar news on "Mayo Clinic study unveils unprecedented method to predict ALS, Parkinson's disease":
- Mayo Clinic researchers use 'genomic pathway' to predict Parkinson's
06-14-2007 · EurekAlert!
A new Mayo Clinic study provides strong evidence that the joint effects of common DNA variations in several genes that encode proteins within a well-defined biological pathway largely explain why some persons get Parkinson's disease while others don't, and even predict with great accuracy at what age people might develop their first symptoms.
Similar news · Read more »
- Mayo Clinic study predicts cardiovascular disease risk for rheumatoid arthritis patients
11-07-2007 · EurekAlert!
People with rheumatoid arthritis have a higher risk for developing heart disease than the general population; however, it is difficult to identify which patients are at increased risk. Researchers at Mayo Clinic have developed a simple approach to predict heart disease in these patients within 10 years of their initial diagnosis of rheumatoid arthritis.
Similar news · Read more »
- Relatives of patients with Parkinson's disease face increased risk of depression/anxiety disorders
12-03-2007 · EurekAlert!
Immediate relatives (brother, sister, mother, father, son or daughter) of people who have Parkinson's disease are at increased risk for developing depression and anxiety disorders, according to a new study by Mayo Clinic. The risk is particularly increased in families of patients who develop Parkinson's disease before age 75. The Mayo Clinic report appears in the December 2007 issue of the journal Archives of General Psychiatry.
Similar news · Read more »
- Researchers find a common genetic risk factor for Parkinson's disease in Asians
01-16-2007 · EurekAlert!
Researchers at Mayo Clinic in Jacksonville, Fla. and the National Taiwan University Hospital in Taipei, Taiwan have discovered what to date appears to be the most common genetic risk factor for ParkinsonЎ's disease worldwide.
Similar news · Read more »
- Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
04-26-2007 · EurekAlert!
A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. Mayo researchers will report their findings on April 26 at the International Society for Heart & Lung Transplantation Annual Meeting and Scientific Session in San Francisco.
Similar news · Read more »
- Researchers identify new therapy for patients with Crohn's disease
05-01-2007 · EurekAlert!
A study led by Mayo Clinic found that adalimumab ((HUMIRA) is an effective treatment for adults with Crohn's disease who do not respond to infliximab (REMICADE)) therapy. These findings were published online today by Annals of Internal Medicine.
Similar news · Read more »
- Researchers: Few heart disease trials reporting sex-specific results
01-30-2007 · EurekAlert!
Heart disease differences in men and women continue to be poorly understood because women are included in clinical trials far less than men, and even when women are included, study results are not reported by sex, according to a study in the current issue of Mayo Clinic Proceedings.
Similar news · Read more »
- Mayo Clinic Cancer Center -- Working on the tough cases
12-11-2006 · EurekAlert!
Mayo Clinic Cancer Center, in collaboration with researchers from the University of Iowa, today presented results of a Phase II clinical study indicating that an oral drug, tipifarnib, can stall or reverse disease progression for patients with relapsed aggressive non-Hodgkin lymphoma.
Similar news · Read more »
- Mayo researchers offer evidence people with psoriasis greater risk for developing heart disease
11-11-2006 · EurekAlert!
People with the skin disorder psoriasis are at increased risk for developing heart disease, according to Mayo Clinic researchers presenting new study data at the American College of Rheumatology Annual Meeting on November 14.
Similar news · Read more »
- Network model predicts risk of death in sickle cell disease
07-11-2007 · EurekAlert!
Researchers from Boston University School of Medicine and Boston University School of Public Health have developed a method to estimate sickle cell disease severity and predict the risk of death in people with this disease. The study appears online in the June issue of the journal Blood.
Similar news · Read more »
